Inactive Instrument

Eucrates Biomedical Acquisition Corp.

EUCR

VGG3141W1068

Eucrates Biomedical Acquisition Corp. announced that it has received $3.5 million in funding from Eucrates Llc

October 26, 2020

On October 27, 2020, Eucrates Biomedical Acquisition Corp. closed the transaction.

Latest news about Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) dropped from NASDAQ Composite Index	23-04-26	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt	23-04-12	CI
Eucrates Biomedical Acquisition to Dissolve, Liquidate	23-04-11	MT
Eucrates Biomedical Acquisition Corp. announced that it has received $0.096 million in funding from Eucrates Llc	23-02-14	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Eucrates Biomedical Acquisition Corp. announced that it has received $0.6 million in funding from Eucrates Llc	22-11-06	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt	22-04-10	CI
Eucrates Biomedical Acquisition Corp. announced that it expects to receive $0.6 million in funding from Eucrates Llc	22-01-19	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-22	CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-07-16	CI
Eucrates Biomedical Acquisition : Receives Non-Compliance Notice from Nasdaq	21-06-01	MT
Certain Ordinary Shares of Eucrates Biomedical Acquisition Corp. are subject to a Lock-Up Agreement Ending on 22-APR-2021.	21-04-21	CI
Eucrates Biomedical Acquisition Corp. Announces Earnings Results for the Period from August 21, 2020 to December 31, 2020	21-03-31	CI
Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) added to NASDAQ Composite Index	20-12-30	CI
Eucrates Biomedical Acquisition Corp. announced that it has received $3.5 million in funding from Eucrates Llc	20-10-26	CI
Eucrates Biomedical Acquisition Corp. has completed an IPO in the amount of $100 million.	20-10-23	CI
Eucrates Biomedical Acquisition Corp. has filed an IPO in the amount of $100 million.	20-10-05	CI
Eucrates Biomedical Acquisition Corp. announced that it expects to receive $3.5 million in funding from Eucrates Llc	20-10-04	CI

Chart Eucrates Biomedical Acquisition Corp.

Duration

Period

Chart Eucrates Biomedical Acquisition Corp.

More charts

Eucrates Biomedical Acquisition Corp. is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The Company intends to focus on businesses focusing on the biomedical or healthcare-related industries. The Company is not engaged in any business operations and has generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+137.37%	5.68B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.27%	819M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+21.31%	552M

Shell Companies